Suppr超能文献

人组织激肽释放酶6和10在胰岛中的免疫组织化学定位

Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.

作者信息

Petraki Constantina D, Karavana Vasso N, Revelos Kyriakos I, Luo Liu-Ying, Diamandis Eleftherios P

机构信息

Department of Pathology, Evangelismos Hospital, Athens, Greece.

出版信息

Histochem J. 2002 Jun-Jul;34(6-7):313-22. doi: 10.1023/a:1023394030036.

Abstract

Tissue kallikreins are thought to be present in the pancreatic islets of Langerhans and to aid in the conversion of proinsulin to insulin. In recent immunohistochemical studies, we observed strong staining of the newly identified human kallikreins 6 and 10 (hK6 and hK10) in the islets of Langerhans. Here, we examine hK6 and hK10 immunoexpression in different types of islet cells of the endocrine pancreas, in order to obtain clues for hK6 and hK10 function in these cells. Ten cases of normal pancreatic tissue, two cases of nesidioblastosis, five insulin-producing tumours and one case of multiple endocrine neoplasia 1 syndrome, containing an insulin-, a somatostatin- and several glucagon-producing tumours, as well as tiny foci of endocrine dysplasia with different predominance of the secreted hormones (mainly glucagon and pancreatic polypeptide) were included in the study. A streptavidin--biotin--peroxidase and an alkaline phosphatase protocol, as well as a sequential immunoenzymatic double staining method were performed, using specific antibodies against hK6, hK10, insulin, glucagon, somatostatin, pancreatic polypeptide, and serotonin. hK6 and hK10 immunoexpression was observed in the islets of Langerhans, including the pancreatic polypeptide-rich islets, in the normal pancreas. Scattered hK6 and hK10 positive cells were localized in relationship with pancreatic acinar cells. In the exocrine pancreas, a cytoplasmic and/or brush border hK6 and hK10 immunoexpression was observed in the median and small sized pancreatic ducts, while the acinar cells were negative. Foci of nesidioblastosis and endocrine dysplasia expressed both kallikreins. hK6 and hK10 were also strongly and diffusely expressed throughout all insulin-, glucagon- and somatostatin-producing tumours. The double staining method revealed co-localization of each hormone and hK6/hK10 respectively, in the same cellular population, in the normal as well as in the diseased pancreas. Our results support the view that hK6 and hK10 may be involved in insulin and other pancreatic hormone processing and/or secretion, as well as in physiological functions related to the endocrine pancreas.

摘要

组织激肽释放酶被认为存在于胰岛中,并有助于胰岛素原转化为胰岛素。在最近的免疫组织化学研究中,我们观察到新发现的人激肽释放酶6和10(hK6和hK10)在胰岛中呈强染色。在此,我们研究hK6和hK10在内分泌胰腺不同类型胰岛细胞中的免疫表达,以便获得hK6和hK10在这些细胞中功能的线索。本研究纳入了10例正常胰腺组织、2例胰岛细胞增殖症、5例胰岛素瘤以及1例多发性内分泌腺瘤1型综合征,后者包含1个胰岛素瘤、1个生长抑素瘤以及多个胰高血糖素瘤,还有微小的内分泌发育异常灶,其分泌的激素(主要是胰高血糖素和胰多肽)优势不同。采用抗hK6、hK10、胰岛素、胰高血糖素、生长抑素、胰多肽和5-羟色胺的特异性抗体,进行了链霉亲和素-生物素-过氧化物酶法、碱性磷酸酶法以及连续免疫酶双染法。在正常胰腺中,hK6和hK10的免疫表达见于胰岛,包括富含胰多肽的胰岛。散在的hK6和hK10阳性细胞定位于与胰腺腺泡细胞相关的部位。在外分泌胰腺中,在中等大小和小的胰管中观察到hK6和hK10的胞质和/或刷状缘免疫表达,而腺泡细胞为阴性。胰岛细胞增殖症灶和内分泌发育异常灶均表达这两种激肽释放酶。hK6和hK10在所有胰岛素瘤、胰高血糖素瘤和生长抑素瘤中也均呈强而弥漫的表达。双染法显示,在正常及病变胰腺中,每种激素分别与hK6/hK10在同一细胞群体中共定位。我们的结果支持以下观点:hK6和hK10可能参与胰岛素及其他胰腺激素的加工和/或分泌,以及与内分泌胰腺相关的生理功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验